ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
ANI Pharmaceuticals (NASDAQ: ANIP) has announced its participation in the upcoming H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ. The company's presentation is scheduled for Tuesday, May 20, 2025, at 1:30pm ET. CEO Nikhil Lalwani and CFO Stephen Carey will represent the company at the conference.
Investors can access the presentation through a live webcast on ANI's website under the Investors section. The webcast recording will remain available for 90 days after the event. One-on-one meetings with management can be arranged through [email protected].
ANI Pharmaceuticals (NASDAQ: ANIP) ha annunciato la sua partecipazione al prossimo H.C. Wainwright 3rd Annual BioConnect Investor Conference presso il NASDAQ. La presentazione dell'azienda 猫 programmata per marted矛 20 maggio 2025, alle 13:30 ET. Il CEO Nikhil Lalwani e il CFO Stephen Carey rappresenteranno la societ脿 durante la conferenza.
Gli investitori potranno seguire la presentazione tramite una diretta streaming disponibile nella sezione Investitori del sito web di ANI. La registrazione del webcast rester脿 accessibile per 90 giorni dopo l'evento. 脠 possibile organizzare incontri individuali con il management scrivendo a [email protected].
ANI Pharmaceuticals (NASDAQ: ANIP) ha anunciado su participaci贸n en la pr贸xima 3陋 Conferencia Anual de Inversores BioConnect de H.C. Wainwright en NASDAQ. La presentaci贸n de la compa帽铆a est谩 programada para el martes 20 de mayo de 2025 a la 1:30 pm ET. El CEO Nikhil Lalwani y el CFO Stephen Carey representar谩n a la empresa en la conferencia.
Los inversores pueden acceder a la presentaci贸n a trav茅s de una transmisi贸n en vivo en el sitio web de ANI en la secci贸n de Inversores. La grabaci贸n del webcast estar谩 disponible durante 90 d铆as despu茅s del evento. Se pueden concertar reuniones individuales con la direcci贸n escribiendo a [email protected].
ANI Pharmaceuticals (NASDAQ: ANIP)臧� 雼り皜鞓る姅 H.C. Wainwright 鞝�3須� 鞐半 BioConnect 韴瀽鞛� 旎嵓霟办姢鞐� NASDAQ鞐愳劀 彀胳棳頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 氚滍憸電� 2025雲� 5鞗� 20鞚� 頇旍殧鞚� 鞓ろ泟 1鞁� 30攵� ET鞐� 鞓堨爼霅橃柎 鞛堨姷雼堧嫟. CEO 雼堩偓 霝勳檧雼堨檧 CFO 鞀ろ嫲敫� 旒�毽皜 旎嵓霟办姢鞐愳劀 須岇偓毳� 雽�響滍暕雼堧嫟.
韴瀽鞛愲摛鞚� ANI 鞗轨偓鞚错姼鞚� 韴瀽鞛� 靹轨厴鞐愳劀 霛检澊敫� 鞗轨簮鞀ろ姼毳� 韱淀暣 氚滍憸毳� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟. 鞗轨簮鞀ろ姼 雲鬼檾電� 頄夓偓 頉� 90鞚� 霃欖晥 鞝滉车霅╇媹雼�. 瓴届榿歆勱臣鞚� 1:1 氙疙寘鞚� [email protected]鞙茧 鞐半澖頃橃棳 鞓堨暯頃� 靾� 鞛堨姷雼堧嫟.
ANI Pharmaceuticals (NASDAQ : ANIP) a annonc茅 sa participation 脿 la prochaine 3e conf茅rence annuelle BioConnect pour investisseurs de H.C. Wainwright au NASDAQ. La pr茅sentation de la soci茅t茅 est pr茅vue pour le mardi 20 mai 2025 脿 13h30 ET. Le PDG Nikhil Lalwani et le directeur financier Stephen Carey repr茅senteront l鈥檈ntreprise lors de la conf茅rence.
Les investisseurs peuvent acc茅der 脿 la pr茅sentation via une diffusion en direct sur le site Web d鈥橝NI, dans la section Investisseurs. L鈥檈nregistrement du webcast restera disponible pendant 90 jours apr猫s l鈥櫭﹙茅nement. Des r茅unions individuelles avec la direction peuvent 锚tre organis茅es en contactant [email protected].
ANI Pharmaceuticals (NASDAQ: ANIP) hat seine Teilnahme an der bevorstehenden 3. j盲hrlichen BioConnect Investorenkonferenz von H.C. Wainwright am NASDAQ angek眉ndigt. Die Pr盲sentation des Unternehmens ist f眉r Dienstag, den 20. Mai 2025, um 13:30 Uhr ET geplant. CEO Nikhil Lalwani und CFO Stephen Carey werden das Unternehmen auf der Konferenz vertreten.
Investoren k枚nnen die Pr盲sentation 眉ber einen Live-Webcast auf der Website von ANI im Bereich Investoren verfolgen. Die Aufzeichnung des Webcasts wird 90 Tage nach der Veranstaltung verf眉gbar sein. Einzelgespr盲che mit dem Management k枚nnen 眉ber [email protected] arrangiert werden.
- None.
- None.
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows:
| Date: | Tuesday, May 20, 2025 |
| 听 | 听 |
| Time: | 1:30pm ET |
| 听 | 听 |
| Webcast: | |
| 听 | 听 |
To schedule a 1x1 meeting with management, please contact
The live and archived webcast will be accessible from the Company鈥檚 website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of 鈥淪erving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit听.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E:
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the H.C. Wainwright BioConnect Conference 2025?
Who will be presenting for ANI Pharmaceuticals at the H.C. Wainwright Conference?
How can investors access ANI Pharmaceuticals' presentation at the BioConnect Conference?
How long will the replay of ANI Pharmaceuticals' BioConnect Conference presentation be available?
